ASX:ALX Atlas Arteria (ALX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Atlas Arteria Stock (ASX:ALX) 30 days 90 days 365 days Advanced Chart Get Atlas Arteria alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.69 million shsAverage VolumeN/AMarket CapitalizationA$7.33 billionP/E Ratio31.31Dividend Yield7.92%Price TargetN/AConsensus RatingN/A Company Overview Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia. Read More Receive ALX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Email Address ALX Stock News HeadlinesWhy Macquarie expects this high-yielding ASX 200 dividend stock to outperformJuly 31 at 2:37 AM | msn.comAtlas Arteria retreats after US toll rates setbackJuly 19, 2025 | msn.comHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.August 2 at 2:00 AM | The Oxford Club (Ad)Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling todayJuly 18, 2025 | msn.comAtlas Arteria Stock Price History - Investing.comJune 26, 2025 | investing.comAtlas Arteria records 6.1% jump in Q1 toll revenueApril 23, 2025 | msn.comASX Market Close: Index pares gains to close flat | March 25, 2025March 25, 2025 | msn.comJefferies Sticks to Their Buy Rating for Atlas Arteria (MAQAF)March 3, 2025 | markets.businessinsider.comSee More Headlines ALX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Atlas Arteria own? Based on aggregate information from My MarketBeat watchlists, some other companies that Atlas Arteria investors own include Adairs (ADH), AMA Group (AMA), ANZ Group (ANZ), Commonwealth Bank of Australia (CBA), Fortescue (FMG), Gilead Sciences (GILD) and Industry, Sector and Symbol Stock ExchangeASX SectorIndustrials Industry Infrastructure Operations Sub-IndustryTrading Current SymbolASX:ALX CIKN/A Webwww.atlasarteria.com Phone61 2 8232 7455FaxN/AEmployees70Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.21 Trailing P/E Ratio31.31 Forward P/E RatioN/A P/E Growth0.31Net IncomeA$300.20 million Net Margins167.02% Pretax MarginN/A Return on Equity3.79% Return on Assets-0.06% Debt Debt-to-Equity Ratio27.23 Current Ratio2.26 Quick Ratio1.77 Sales & Book Value Annual SalesA$140.10 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.65 Book ValueA$4.21 per share Price / BookN/AMiscellaneous Outstanding Shares1,450,000,000Free FloatN/AMarket CapA$7.33 billion OptionableNot Optionable Beta0.78 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (ASX:ALX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlas Arteria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.